Literature DB >> 12130431

Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients.

P Gupta1, C Mordin, J Curtis, J M B Hughes, C L Shovlin, J E Jackson.   

Abstract

OBJECTIVE: This study assessed the effect and safety of percutaneous transcatheter coil embolization of pulmonary arteriovenous malformations.
MATERIALS AND METHODS: In 58 (88%) of 66 patients, all malformations with feeding vessels greater than or equal to 3 mm in diameter were embolized with steel coils. Arterial oxygen saturation at rest and exercise, intrapulmonary right-to-left anatomic shunt fraction ((99m)Tc-macroaggregate injection), maximum exercise capacity (incremental work rate test), and pulmonary function were measured before and after embolization. Complications were analyzed.
RESULTS: Three categories of patients were identified. Patients in group 1 (27%) had complete occlusion of all angiographically visible pulmonary arteriovenous malformations; patients in group 2 (61%) had complete occlusion of all malformations with feeding vessels greater than or equal to 3 mm in diameter, but with smaller lesions persisting; and patients in group 3 (12%) had incomplete embolization, with feeding vessels greater than or equal to 3 mm in diameter remaining. The mean right-to-left shunt after embolization was least in group 1 (7%), intermediate in group 2 (10%), and greatest in group 3 (19%). Arterial oxygen saturation and right-to-left shunt fraction returned to normal levels (>96% and <3.5%, respectively) in 33% of patients. A significant improvement occurred after embolization in carbon monoxide diffusing capacity per unit of alveolar volume and in exercise capacity in 16 and 10 patients, respectively. In 93 procedures, 12 complications (13%) occurred.
CONCLUSION: Coil embolization of pulmonary arteriovenous malformations is effective in reducing right-to-left anatomic shunt fraction and in improving arterial oxygenation. Coil embolization of pulmonary arteriovenous malformations is well tolerated and has a low complication rate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130431     DOI: 10.2214/ajr.179.2.1790347

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  27 in total

1.  Management of pulmonary arteriovenous malformations.

Authors:  Mary E Meek; James C Meek; Michael V Beheshti
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 2.  Embolisation for pulmonary arteriovenous malformation.

Authors:  Charlie C-T Hsu; Gigi Nc Kwan; Hannah Evans-Barns; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2018-01-04

Review 3.  Pulmonary arteriovenous malformations: endovascular therapy.

Authors:  Murthy R Chamarthy; Harold Park; Patrick Sutphin; Girish Kumar; Daniel Lamus; Sachin Saboo; Matthew Anderson; Sanjeeva P Kalva
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

4.  Embolotherapy for pulmonary arteriovenous malformations in patients without hereditary hemorrhagic telangiectasia.

Authors:  Ji Hoon Shin; Soo Jin Park; Gi-Young Ko; Hyun-Ki Yoon; Dong-Il Gwon; Jin-Hyoung Kim; Kyu-Bo Sung
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

5.  Interventional embolization of a giant pulmonary arteriovenous malformation with right-left-shunt associated with hereditary hemorrhagic telangiectasia.

Authors:  M Hinterseer; A Becker; A S Barth; R Kozlik-Feldmann; B J Wintersperger; J Behr
Journal:  Clin Res Cardiol       Date:  2006-01-19       Impact factor: 5.460

6.  Successful lobectomy for central large pulmonary arteriovenous malformation.

Authors:  Takashi Kanou; Yasushi Shintani; Keigo Osuga; Meinoshin Okumura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-20

7.  Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life.

Authors:  A J Easey; G M F Wallace; J M B Hughes; J E Jackson; W J Taylor; C L Shovlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

8.  Pulmonary arteriovenous malformations: percutaneous treatment preserving parenchyma in high-flow fistulae.

Authors:  M Grosso; F Groppo Marchisio; F Testa; G Gallarato; A Balderi; G Lingua; I Mondino; F Pedrazzini; C Danesino; E Buscarini
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

9.  Imitators of exercise-induced bronchoconstriction.

Authors:  Pnina Weiss; Kenneth W Rundell
Journal:  Allergy Asthma Clin Immunol       Date:  2009-11-17       Impact factor: 3.406

10.  Pulmonary arteriovenous malformations presenting as difficult-to-control asthma: a case report.

Authors:  Marta Navratil; Vinko Vidjak; Filip Rubić; Damir Erceg; Mirjana Turkalj
Journal:  J Med Case Rep       Date:  2013-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.